CLVSF News Alert Cellavision Ab (CLVSF) 3.3344 09/26/2014 07

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cellavision Ab (CLVSF) 3.3344 $CLVSF

CellaVision AB: Interim Report January-June 2014
Thomson Reuters ONE - Fri Jul 18, 1:20AM CDT
Continued strong sales growth of 50 percent

CellaVision acquires a new technology platform
Thomson Reuters ONE - Mon Jun 23, 8:01AM CDT
This information was released for public disclosure on June 23, 2014 at 3.00 pm CET.

CellaVision revises outlook for the full year: Sales growth in 2013
Thomson Reuters ONE - Wed Jan 15, 1:26AM CST
CellaVision announces that sales for the fourth quarter of 2013 has increased significantly in comparison with the corresponding quarter in 2012. This means that the company shows sales growth for the full year 2013, in contrast to what was communicated in the company's half-year report 2013.

CellaVision AB: Interim report January - June 2013
Thomson Reuters ONE - Wed Jul 17, 1:31AM CDT
Weak quarter but continued global market initiatives and sales successes in Asia

CellaVision appoints new heads of Quality Assurance and Scientific Affairs
Thomson Reuters ONE - Mon Jun 24, 1:31AM CDT
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care services, strengthens its organization with new positions in quality and scientific affairs. Goran Granqvist has been appointed VP Quality, responsible for Quality Assurance and part of the management team. Hans-Inge Bengtsson takes a new role as Director Scientific Affairs.

Sweden's Equalis invests in CellaVision's new product for external quality assurance of laboratory tests in hematology
Thomson Reuters ONE - Tue May 07, 4:02AM CDT
CellaVision has signed an agreement with Equalis, the Swedish provider of external quality assessment for clinical laboratory tests. Equalis has chosen to invest in CellaVision's new proficiency testing program for the identification of cells in blood and other body fluids, CellaVision® Proficiency Software. The order comprises a license for 350 users.

Bulletin from the Annual General Meeting of CellaVision AB (publ) held on April 24, 2013
Thomson Reuters ONE - Wed Apr 24, 12:39PM CDT
CellaVision AB (publ) held its Annual General Meeting today, April 24, 2013, in Lund. The meeting resolved upon the following:

CellaVision AB: Interim report January - March 2013
Thomson Reuters ONE - Wed Apr 24, 7:02AM CDT
More sales channels increase our growth opportunities but the year got off to a weak start

CellaVision and Sysmex announce a jointly-developed product for hematology labs
Thomson Reuters ONE - Tue Apr 16, 8:01AM CDT
This information was released for public disclosure on April 16, 2013 at 3.00 pm CET.

CellaVision and Beckman Coulter enhance partnership by adding EMEA to their global distribution agreement
Thomson Reuters ONE - Mon Apr 08, 1:26AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

CellaVision's 2012 Annual Report now available
Thomson Reuters ONE - Wed Apr 03, 2:01AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

Notice of Annual General Meeting in CellaVision AB, April 24, 2013
Thomson Reuters ONE - Thu Mar 21, 2:31AM CDT
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

NeuroVive Appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors
PR Newswire - Mon Mar 18, 5:06AM CDT
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company's Board. Both have exceptional track records and leadership experience and are expected to make a significant contribution to NeuroVive.

CellaVision launches a new product for proficiency testing
Thomson Reuters ONE - Tue Mar 05, 7:01AM CST
CellaVision, which develops and sells products for routine analysis of blood and other body fluids in health care, is launching a new product for internal and external quality assurance and proficiency testing of laboratory analyses. The product, CellaVision® Proficiency Software, targets clinical laboratories that assess and perform the classification of blood cells, as well as accredited providers of external quality assessment schemes for laboratory medicine.

CellaVision adds another distribution agreement for the European market
Thomson Reuters ONE - Mon Feb 25, 5:01AM CST
This information was released for public disclosure on February 25, 2013 at 12.00 am CET.

CellaVision AB: Year-end bulletin 2012
Thomson Reuters ONE - Thu Feb 14, 1:21AM CST
Growth of 9 per cent and strengthened market position




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infiterra Streamlines Subscription Commerce for MSPs

Updated Category News Views 53

Revolutionizing How MSPs Navigate Subscription Commerce Just when you thought subscription commerce for IT might plateau, Infiterra's stepping up with some slick integration magic. They're rolling out tools that are about to make life a lot easier for Managed Service Providers (MSPs) and IT distributors. Yeah, the technological world spins fast, and these folks want in on...

Continue Reading
Urenco's LEU+ Boosts Future Nuclear Reactor Options

Updated Category News Views 16

Urenco's Leap Forward with LEU+ Well, look who’s shaking up the nuclear scene—Urenco USA, that’s who. They’ve just churned out their first cylinder of low-enriched uranium plus (LEU+) at the National Enrichment Facility in Eunice, New Mexico. This isn’t just any regular Tuesday of uranium talk; it marks a seismic shift for nuclear fuel options in the Western...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 0

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Milwaukee Cylinder Unveils Tech for Longevity in Tough Conditions

Updated Category News Views 54

Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...

Continue Reading
Tips to Pick the Right Primary Care Provider

Updated Category News Views 0

Deciding on Your Healthcare Anchor The quest for the perfect primary care provider isn't just routine; it's a cornerstone to your overall healthcare strategy. When Healthcare Services Expert Sheila A. Berschauer from Moses Lake Community Health lays it all out in HelloNation, she pinpoints selecting a provider as one of the mightiest decisions in your health journey. This...

Continue Reading
Silicone Fluids Market Forecast Hits $10.15B by 2031

Updated Category News Views 84

Unpacking the Prevailing Expansion The global silicone fluids market is marching on a path to significant growth, projected to hit a hefty $10.15 billion by 2031. Now, if you think that's just another number, let's break down why this matters and how the market is changing its stripes. The Rising Tide of Silicone Applications Silicone fluids are not just sliding under the...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 119

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading
Downsizing Tips for Seniors: Start Early, Plan Smart

Updated Category News Views 13

When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 53

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
ATS Energy Adds Shell Veteran to Fuel Big Ambitions

Updated Category News Views 0

ATS Energy: Charging Ahead with New Leadership There's nothing quite like the spark of new leadership to rev up the energy sector, and ATS Energy—fresh off its Earthshot Prize win—has just thrown in a turbocharged trio. Bringing in seasoned pros with stacks of industrial technology, finance, and infrastructure chops, this isn't your run-of-the-mill board shakeup. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Jones Lang LaSalle's Impressive Growth Potential

Updated Category News Views 167

Analyzing the Growth of Jones Lang LaSalle Jones Lang LaSalle (NYSE: JLL) has delivered remarkable results in the investment landscape over the past five years, showcasing an annualized return that exceeds market expectations by 5.97%. This impressive figure translates into an average annual return of 21.36%, highlighting the strength and reliability of JLL as an...

Continue Reading
Akari Therapeutics to Present at Annual Cancer Meeting

Updated Category News Views 155

Exciting Presentation by Akari Therapeutics at Upcoming Conference Akari Therapeutics, Plc (NASDAQ: AKTX), a pioneering oncology biotechnology firm specializing in antibody drug conjugates (ADCs), has recently achieved a significant milestone. Their abstract has been accepted for oral presentation at a major cancer conference, poised to take place in the near future. This...

Continue Reading
Anchin Expands Leadership with Two New Partners Joining

Updated Category News Views 181

Anchin Welcomes New Partners to Its Growing Team Anchin, a prominent accounting and advisory firm, has exciting news to share about its team's expansion. The firm is proud to announce the addition of two accomplished professionals, Ryan Babiak and Thomas Miranda, to its partnership. As a tax partner and an audit partner, respectively, they bring fresh expertise and...

Continue Reading
StarKist Partners with Kyle Busch Family for Exciting Season

Updated Category News Views 155

StarKist and the Busch Family Kick Off NASCAR 2026 As the exhilarating NASCAR season launches, StarKist Co. is excited to announce its partnership with NASCAR champion Kyle Busch, wellness advocate Samantha Busch, and young racer Brexton Busch. Building upon a successful initial year, this collaboration emphasizes the importance of healthy, ready-to-eat protein options...

Continue Reading
Highlighting Major Tech Developments: Key Releases This Month

Updated Category News Views 177

July in Review: Key Technology Announcements July saw a flurry of significant announcements in the tech world, showcasing innovations and strategies that are set to redefine various industries. This roundup offers insights into the most noteworthy developments that emerged throughout the month. Premarket Highlights Several announcements captured the industry’s...

Continue Reading